These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7784308)

  • 1. Protective effect of propionyl-L-carnitine against PAF-induced rat paw oedema.
    Caruso A; Cutuli VM; De Bernardis E; Leonardi G; Amico-Roxas M
    Pharmacol Res; 1995 Jan; 31(1):67-72. PubMed ID: 7784308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effects of propionyl-L-carnitine on plasma extravasation induced by irritants in rodents.
    Amico-Roxas M; Caruso A; Cutuli VM; de Bernardis E; Leonardi G
    Drugs Exp Clin Res; 1993; 19(5):213-7. PubMed ID: 8174493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombosis induced by endothelin (ET-1) and carrageenin in rats treated with indomethacin and propionyl carnitine.
    Bertelli A; Bertelli AA; Galmozzi G; Giovannini L; Mian M
    Drugs Exp Clin Res; 1993; 19(2):75-8. PubMed ID: 8223146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effect of a pyrrolizidine alkaloid, crotalaburnine, on rat paw oedema and cotton pellet granuloma.
    Ghosh MN; Singh H
    Br J Pharmacol; 1974 Aug; 51(4):503-8. PubMed ID: 4451764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The anti-inflammatory effects of the phosphodiesterase inhibitor pentoxifylline in the rat.
    Abdel-Salam OM; Baiuomy AR; El-Shenawy SM; Arbid MS
    Pharmacol Res; 2003 Apr; 47(4):331-40. PubMed ID: 12644391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential inhibition by two hetrazepine PAF antagonists of acute inflammation in the mouse.
    Henriques MG; Weg VB; Martins MA; Silva PM; Fernandes PD; Cordeiro RS; Vargaftig BB
    Br J Pharmacol; 1990 Jan; 99(1):164-8. PubMed ID: 2331569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of propionyl-L-carnitine in humans: evidence for saturable tubular reabsorption.
    Pace S; Longo A; Toon S; Rolan P; Evans AM
    Br J Clin Pharmacol; 2000 Nov; 50(5):441-8. PubMed ID: 11069438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of carrageenin-induced rat paw oedema by crotapotin, a polypeptide complexed with phospholipase A2.
    Landucci EC; Antunes E; Donato JL; Faro R; Hyslop S; Marangoni S; Oliveira B; Cirino G; de Nucci G
    Br J Pharmacol; 1995 Feb; 114(3):578-83. PubMed ID: 7537590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of platelet-activating factor synthesis in human neutrophils and platelets by propionyl-L-carnitine.
    Triggiani M; Oriente A; Golino P; Gentile M; Battaglia C; Brevetti G; Marone G
    Biochem Pharmacol; 1999 Oct; 58(8):1341-8. PubMed ID: 10487538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The potentiating effect of propionyl carnitine on prostacycline prevention of thrombosis induced by endothelin (ET-1) and K-carrageenin.
    Bertelli A; Bertelli AA; Giovannini L
    Drugs Exp Clin Res; 1994; 20(1):7-11. PubMed ID: 7924894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitric oxide: a key mediator in the early and late phase of carrageenan-induced rat paw inflammation.
    Salvemini D; Wang ZQ; Wyatt PS; Bourdon DM; Marino MH; Manning PT; Currie MG
    Br J Pharmacol; 1996 Jun; 118(4):829-38. PubMed ID: 8799551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Propionyl-L-carnitine as potential protective agent against adriamycin-induced impairment of fatty acid beta-oxidation in isolated heart mitochondria.
    Sayed-Ahmed MM; Shouman SA; Rezk BM; Khalifa MH; Osman AM; El-Merzabani MM
    Pharmacol Res; 2000 Feb; 41(2):143-50. PubMed ID: 10623482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Propionyl-L-carnitine as protector against adriamycin-induced cardiomyopathy.
    Sayed-Ahmed MM; Salman TM; Gaballah HE; Abou El-Naga SA; Nicolai R; Calvani M
    Pharmacol Res; 2001 Jun; 43(6):513-20. PubMed ID: 11419959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors influencing the inhibitory action of anti-inflammatory drugs on carrageenin induced oedema.
    Green AY; Green D; Murray PA; Wilson AB
    Br J Pharmacol; 1971 Jan; 41(1):132-9. PubMed ID: 5547756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salicylates inhibit PAF-acether-induced rat paw oedema when cyclooxygenase inhibitors are ineffective.
    Cordeiro RS; Silva PM; Martins MA; Vargaftig BB
    Prostaglandins; 1986 Nov; 32(5):719-27. PubMed ID: 3103172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelin-1 inhibits PAF-induced paw oedema and pleurisy in the mouse.
    Henriques MG; Rae GA; Cordeiro RS; Williams TJ
    Br J Pharmacol; 1992 Jul; 106(3):579-82. PubMed ID: 1504742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Propionyl-L-carnitine effects on postischemic recovery of heart function and substrate oxidation in the diabetic rat.
    Broderick TL; Driedzic W; Paulson DJ
    Mol Cell Biochem; 2000 Mar; 206(1-2):151-7. PubMed ID: 10839205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet activating factor potentiates rat paw oedema induced by different phlogogen agents.
    Izzo AA; Mascolo N; Di Urno MV; Autore G; Di Carlo G; Capasso F
    Agents Actions; 1994 May; 41(3-4):140-3. PubMed ID: 7524288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional and metabolic effects of propionyl-L-carnitine in the isolated perfused hypertrophied rat heart.
    Motterlini R; Samaja M; Tarantola M; Micheletti R; Bianchi G
    Mol Cell Biochem; 1992 Oct; 116(1-2):139-45. PubMed ID: 1480142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of carrageenan-induced edema by indomethacin or sodium salicylate does not prevent the increase of nerve growth factor in the rat hind paw.
    Amann R; Schuligoi R
    Neurosci Lett; 2000 Jan; 278(3):173-6. PubMed ID: 10653021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.